down arrow

Natco Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
767.90
21.05 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

752.20783.70

52 Week

660.051,638.35
Valuation
Technical
Day's Volume

CASH

4.33 lacs (-50.08%) Volume

Shareholding (Dec 2024)

FII

17.94%

Held by 351 FIIs

DII

5.57%

Held by 18 DIIs

Promoter

49.62%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • PBT LESS OI(Q) At Rs -12.60 cr has Fallen at -102.3% (vs previous 4Q average)
  • PAT(Q) At Rs 133.00 cr has Fallen at -72.6% (vs previous 4Q average)
  • NET SALES(Q) Lowest at Rs 474.80 cr
2

Stock is technically in a Bearish range

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 13,754 Cr (Mid Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.80%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

27.20%

stock-summary
Price to Book

1.87

Revenue and Profits (1 Year):
Net Sales:
475 Cr
(Quarterly Results - Dec 2024)
Net Profit:
133 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.8%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-46.53%
0.23%
-46.3%
1 Year
-19.62%
0.59%
-19.03%
2 Years
32.48%
2.52%
35.0%
3 Years
-8.41%
3.08%
-5.33%
4 Years
-16.69%
2.77%
-13.92%
5 Years
31.34%
5.33%
36.67%

Latest dividend: 1.5 per share ex-dividend date: Feb-18-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.42%
EBIT Growth (5y)
30.72%
EBIT to Interest (avg)
53.46
Debt to EBITDA (avg)
0.51
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.52
Tax Ratio
17.65%
Dividend Payout Ratio
12.25%
Pledged Shares
0
Institutional Holding
23.51%
ROCE (avg)
17.77%
ROE (avg)
15.27%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
33
Price to Book Value
1.87
EV to EBIT
5.91
EV to EBITDA
5.38
EV to Capital Employed
2.17
EV to Sales
2.70
PEG Ratio
0.16
Dividend Yield
0.80%
ROCE (Latest)
41.06%
ROE (Latest)
27.20%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 51 Schemes (1.92%)

FIIs

Held by 351 FIIs (17.94%)

Promoter with highest holding

V C Nannapaneni (15.66%)

Highest Public shareholder

Life Insurance Corporation Of India - P & Gs Fund (2.29%)

Individual Investors Holdings

23.34%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -65.37% vs 0.62% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -80.36% vs 1.32% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "474.80",
          "val2": "1,371.10",
          "chgp": "-65.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.80",
          "val2": "804.30",
          "chgp": "-95.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "4.10",
          "chgp": "7.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "133.00",
          "val2": "677.30",
          "chgp": "-80.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.17%",
          "val2": "58.66%",
          "chgp": "-50.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 25.87% vs 64.95% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 70.51% vs 109.25% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,733.70",
          "val2": "2,171.90",
          "chgp": "25.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,609.10",
          "val2": "986.00",
          "chgp": "63.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.30",
          "val2": "8.40",
          "chgp": "10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,345.80",
          "val2": "789.30",
          "chgp": "70.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "58.86%",
          "val2": "45.40%",
          "chgp": "13.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 9.49% vs 61.98% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 47.58% vs 127.99% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,208.50",
          "val2": "2,930.50",
          "chgp": "9.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,647.90",
          "val2": "1,254.10",
          "chgp": "31.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.70",
          "val2": "13.00",
          "chgp": "5.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,478.80",
          "val2": "1,002.00",
          "chgp": "47.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.36%",
          "val2": "42.79%",
          "chgp": "8.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,998.80",
          "val2": "2,707.10",
          "chgp": "47.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,751.40",
          "val2": "935.60",
          "chgp": "87.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.20",
          "val2": "14.50",
          "chgp": "32.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,388.30",
          "val2": "715.30",
          "chgp": "94.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "43.80%",
          "val2": "34.56%",
          "chgp": "9.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
474.80
1,371.10
-65.37%
Operating Profit (PBDIT) excl Other Income
38.80
804.30
-95.18%
Interest
4.40
4.10
7.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
133.00
677.30
-80.36%
Operating Profit Margin (Excl OI)
8.17%
58.66%
-50.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -65.37% vs 0.62% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -80.36% vs 1.32% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,733.70
2,171.90
25.87%
Operating Profit (PBDIT) excl Other Income
1,609.10
986.00
63.19%
Interest
9.30
8.40
10.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,345.80
789.30
70.51%
Operating Profit Margin (Excl OI)
58.86%
45.40%
13.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 25.87% vs 64.95% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 70.51% vs 109.25% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,208.50
2,930.50
9.49%
Operating Profit (PBDIT) excl Other Income
1,647.90
1,254.10
31.40%
Interest
13.70
13.00
5.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,478.80
1,002.00
47.58%
Operating Profit Margin (Excl OI)
51.36%
42.79%
8.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 9.49% vs 61.98% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 47.58% vs 127.99% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,998.80
2,707.10
47.72%
Operating Profit (PBDIT) excl Other Income
1,751.40
935.60
87.20%
Interest
19.20
14.50
32.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,388.30
715.30
94.09%
Operating Profit Margin (Excl OI)
43.80%
34.56%
9.24%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Natco Pharma Ltd. stock-summary
stock-summary
Natco Pharma Ltd.
Mid Cap
Pharmaceuticals & Drugs
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
Company Coordinates stock-summary
Company Details
Natco House, Road No 2 Banjara Hills Hyderabad Telangana : 500033
stock-summary
Tel: 91-040-23547532
stock-summary
http://www.natcopharma.co.in
stock-summary
investors@natcopharma.co.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."